How Ginkgo Bioworks Holdings, Inc. stacks up

DNA · against 478 other Healthcare companies of similar size

Overall

19/ 100

Near the bottom of its peers.

Ranked #461 of 479 · scores higher than 4% of peers

Bars: peers in each 10-point band of the overall score

13 peers with an overall score of 10–19, including DNA · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#256 of 487Score 45 / 100 · beats 46%Growth#423 of 437Score 2 / 100 · beats 1%Profitability#421 of 481Score 13 / 100 · beats 11%Risk#417 of 493Higher relative risk · safety 17 · beats 15%

Ranking by overall score

Top 5 and the companies ranked around DNA

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Arbutus Biopharma CorporationABUS · US-listed	595M USD	97	96	98	99	0 / 2
2	Zevra Therapeutics, Inc.ZVRA · US-listed	609M USD	91	95	99	99	0 / 2
3	Beijing Chunlizhengda Medical Instruments Co., Ltd.1858.HK · Hong Kong	2.9B HKD (≈$365M)	84	99	63	86	0 / 2
4	Amoy Diagnostics Co., Ltd.300685.SZ · China	7.5B CNY (≈$1.1B)	82	72	64	96	0 / 2
5	CorMedix Inc.CRMD · US-listed	433M USD	81	96	99	99	2 / 2
⋯
455	Staidson (Beijing) BioPharmaceuticals Co., Ltd.300204.SZ · China	9.1B CNY (≈$1.3B)	20	0	2	26	1 / 2
455	Aclaris Therapeutics, Inc.ACRS · US-listed	551M USD	20	8	5	4	1 / 2
455	OPKO Health, Inc.OPK · US-listed	1.3B USD	20	8	8	31	2 / 2
461	Lionco Pharmaceutical Group Co.,Ltd.603669.SS · China	3.7B CNY (≈$518M)	19	0	17	32	2 / 2
461	Ginkgo Bioworks Holdings, Inc.DNA · US-listed	725M USD	19	45	2	13	2 / 2
463	Harbin Medisan Pharmaceutical Co., Ltd.002900.SZ · China	3.1B CNY (≈$440M)	18	0	6	27	1 / 2
463	Zhejiang Wecome Pharmaceutical Company Limited300878.SZ · China	4.0B CNY (≈$563M)	18	0	2	26	1 / 2
463	Chimin Health Management Co., Ltd.603222.SS · China	3.5B CNY (≈$496M)	18	0	12	31	2 / 2
466	Heilongjiang ZBD Pharmaceutical Co., Ltd.603567.SS · China	4.6B CNY (≈$645M)	17	0	0	25	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…